Beaumont Hospital — Clinical Trial Site

133 Registered trials

52 Currently recruiting

Organisation

Beaumont Hospital

Location

Dublin 9, Ireland

Identifier

ORG-100041548

Address

Beaumont Road, Beaumont, D09 V2N0, Ireland

Departments

#191: Respiratory medicine
2200: Main Building
372004: Department of Haematology
3903:Oncology
3904:Oncology
8042:Oncology
Anaesthesia and Critical Care
Cancer Clinical Trials & Research Unit
Cancer Clinical Trials and Research Unit
Cancer Clinical Trials Research Unit
Cancer Clinical Trials Unit
Cancer Clinical Trials Unit & Research Unit
Clinical Oncology
Clinical Research Centre
Clinical Trials & Research Unit
D10-514 : Nephrology
Department of Haematology
Department of Medicine
Department of Medicine, RCSI
Department of Medicine/ RCSI
Dept. of Anaesthesia and Intensive Care Medicine
Emergency Medicine
Endocrinology
Gastroenterology
Gastroenterology and Hepatology
Gastroenterology Department
Haematology
Haematology department
Hepatology Unit
ICU
Infectious Diseases
Intensive Care Unit
Medical Oncology
N/A
NA
Neurology
Neurology Department
Not Applicable
Oncology
Oncology Department
Oncology Clinical Trials Unit
Oncology department
Onkology
Respiratory
Respiratory Medicine
Rheumatology
Rheumatology Department
Royal College of Surgeons in Ireland (RCSI)
Stroke

Clinical trials at this site (133)

Search interface

Clinical trial of MK-7648A in adults and children with skin cancer Not authorised

2022-501417-31-00 High-risk Resected Melanoma 5
HARMONi-3 Not authorised

2023-504989-37-00 Metastatic Squamous Non-small Cell Lung Cancer 5
A prospective, open-label, randomized, multicenter phase-III trial to evaluate the efficacy of pirtobrutinib and epcoritamab compared with R… Pending

2024-513445-37-00 previously untreated RT, irrespective of risk factors a 5
STAMPEDE2: A randomised controlled platform trial testing treatments in metastatic hormone sensitive prostate cancer Pending

2025-522145-21-00 Metastatic hormone sensitive prostate cancer 5
Usnoflast Neuromuscular Investigation for Treatment Efficacy in ALS (UNITE-ALS) Pending

2025-522580-15-00 Amyotrophic Lateral Sclerosis (ALS) 4
Safety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis Pending

2025-523400-72-00 Cystic fibrosis 4
A Phase 1 Study of AIR-001 in Adults with AATD. Pending

2025-523558-14-00 Alpha-1 Antitrypsin Deficiency 1
A Study of Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants with Unresectable Stage III NSCLC Pending

2025-523576-23-00 Unresectable Stage III non-small cell lung cancer witho 5
Efficacy and safety of vamifeport in adult subjects with HFE-related hereditary hemochromatosis Pending

2025-523793-16-00 Homeostatic iron regulator gene-related hereditary hemo 4
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS) Recruiting

2025-524002-16-00 Amyotrophic Lateral Sclerosis 5 2026-05-12
A study to investigate the effect of adding bleximenib to standard-of-care treatment with intensive chemotherapy in patients with a specific… Recruiting

2025-522767-15-00 Acute Myeloid Leukemia 5 2026-01-27
A clinical study to assess the efficacy of adjuvant immunotherapy with cemiplimab in patients with surgically removed non-small cell lung ca… Recruiting

2024-519901-36-00 Patients with resected stage II-IIIA non-small cell lun 5 2025-12-17
A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008) Recruiting

2024-518296-56-00 Crohn’s Disease 5 2025-09-29
A study investigating the effect of adding revumenib to treatment with venetoclax + azacitidine in patients with acute myeloid leukemia (AML… Recruiting

2024-512733-32-00 Acute Myeloid Leukemia (AML) 5 2025-03-31
A clinical trial to learn about the effects of VHB937 in people with amyotrophic lateral sclerosis (ALS) Recruiting

2024-512536-29-00 Amyotrophic Lateral Sclerosis (ALS) 4 2025-02-28
An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients w… Recruiting

2023-507853-13-00 Ulcerative Colitis 4 2025-02-25
A study comparing niraparib with temozolomide in adult participants with newly-diagnosed, MGMT unmethylated glioblastoma Recruiting

2024-513077-48-00 O6-methylguanine methyltransferase (MGMT) unmethylated 5 2024-12-19
A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better than Anti-PD1 Alone in Adult Participants with Resectable Stage 3 or 4… Recruiting

2022-502825-17-00 Melanoma 4 2024-10-07
A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participant… Recruiting

2023-505678-14-00 Ulcerative Colitis 4 2024-08-19
Disitamab Vedotin with Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 Recruiting

2022-501105-12-00 Urothelial Carcinoma 5 2024-07-15
Mirvetuximab soravtansine in combination with bevacizumab for the maintenance treatment of adult patients with FRα-high recurrent platinum-s… Recruiting

2022-501606-35-01 Platinum-sensitive epithelial ovarian, fallopian tube, 11 2024-02-21
Early Sedation with Dexmedetomidine vs. Placebo in Older Ventilated Critically Ill Patients Recruiting

2022-501157-36-00 Critically ill patients who are dependent on high level 6 2024-02-07
Evaluation of epithelial ovarian, primary peritoneal, or fallopian tube cancer treatment in first recurrance using platinum-based chemothera… Recruiting

2022-501220-14-00 epithelial ovarian, primary peritoneal, or fallopian tu 4 2023-10-17
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants with Early Breast Cancer (EMBER-4) Recruiting

2022-501007-28-00 Breast Neoplasms 5 2023-04-18